False
Advertisement
November 2019
For our November issue, we set our sights on diabetes. In our cover feature, three “diabetic eye disease” gurus, Neil Bressler, Andrew Schimel and Heeral Shah, share their insights on the prevention, detection, diagnosis and treatment of diabetes-related disorders and discuss how treatments are going to evolve in the future. Anat Loewenstein calls for a systemic approach to these disorders, while Steve Charles argues that AI is not a serious solution to the tactical and strategic issues of the current diabetic retinopathy epidemic. We also delve into the new aflibercept regimen and discover how it can reduce the burden of treatment for many patients. The use of tear osmolarity and MMP-9 as the basis for an ocular surface disease treatment algorithm is also discussed, and piezo-print technology is highlighted as a potential solution for many of the issues associated with topical eye medications. Jennifer Stambook gives her take on how patient engagement needs to evolve in the digital age, while David Mandell and Carole Foos share the second part of their guide to building and protecting finances for mid-career ophthalmologists, and those approaching retirement. Finally, we sit down with Ravi Goel, ophthalmic surgeon at Wills Eye Hospital, USA.
Residency to Retirement: Part Two
November 11, 2019
The definitive guide to building – and protecting – your finances
1 min read
Setting Our Sights on Diabetes
November 8, 2019
Three diabetic eye disease gurus discuss prevention, detection, diagnosis, and treatment – and explain why it’s important to consider the future
1 min read
Patient Engagement in the Digital Age
November 7, 2019
New generations of patients use services in novel ways – and ophthalmic practices must constantly readjust to keep up
1 min read
Dazed and Confused
November 5, 2019
Eye-tracking technology presents promising biomarkers for identifying traumatic brain injury
1 min read
Smart, But Not Smart Enough
November 4, 2019
AI image interpretation will not solve the diabetic retinopathy epidemic
1 min read
OSD Decisions
November 1, 2019
Using tear osmolarity and MMP-9 as the basis of an ocular surface disease treatment algorithm
1 min read
Shifting the AMD Burden-Benefit Balance
October 29, 2019
Aflibercept’s newly approved administration regime permits a reduction in intravitreal injection frequency – and recent clinical trial data (ALTAIR) suggest that extended interval dosing can sustain robust vision gains over 2 years
1 min read
NICE to Have
October 28, 2019
Until recently, RPE65 mutations almost always resulted in blindness – but now, NICE’s recommendation of voretigene neparvovec means these retinal dystrophy patients have another option
1 min read
It's All in the Genes
October 26, 2019
15-year study uncovers first known genetic cause for rare retinal disease
1 min read
Leading, Advocating, Challenging
October 25, 2019
Sitting Down With… Ravi Goel, Ophthalmic Surgeon, Wills Eye Hospital, USA
1 min read
Fine Print
October 24, 2019
Topical piezo-print technology could solve many of the problems associated with use of topical eye medications– and ultimately change the game in myopic progression
1 min read
Patient Management 2.0
October 23, 2019
Diabetes prevalence is set to grow by 48 percent over the next 25 years – where does that leave ophthalmologists?
1 min read
Shifting to a Systemic Approach
October 18, 2019
What does the future hold for the management – and treatment – of diabetic eye disease?
1 min read
Browse by Subspecialties
False
Advertisement